Anzeige
Mehr »
Login
Mittwoch, 15.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Löst diese riesige Entdeckung die Kupferkrise der KI? So ändert sich die Rechnung durch diesen Explorer!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
664 Leser
Artikel bewerten:
(2)

Li-Metal Corp.: Li-Metal Selected for $5 Million Industry Consortium to Advance Lithium Metal Solid-State Batteries

Finanznachrichten News

Funding to accelerate the development of Li-Metal's technologies in support of a sustainable domestic battery materials supply chain

TORONTO, ON / ACCESSWIRE / April 29, 2022 / Li-Metal Corp. (CSE:LIM) (OTC PINK:LIMFF) (FSE:5ZO) ("Li-Metal" or the "Company"), a leading developer of lithium metal anode and lithium metal technologies critical for next-generation batteries, is pleased to announce that it has been granted CAD$1.9 million ("the Grant"), as part of a CAD$5.1 million joint project with Blue Solutions, awarded by Next Generation Manufacturing Canada (NGen), an industry-led organization supporting advanced manufacturing in Canada, to develop the Company's lithium metal anode technologies.

"If we want to win business in the globally competitive EV market, Canada must invest in world-leading advanced manufacturing capabilities, in the cleanest, most cutting-edge technologies and processes," said Jayson Myers, CEO, NGen. "That's why NGen has co-invested with Li-Metal and Blue Solutions in game-changing technologies that will sustainably drive the next generation of EV batteries, resulting in cleaner, more efficient electric vehicles and driving new investment and employment opportunities for businesses across Canada.

"We are excited to receive NGen's support as we continue to advance the development of lithium metal and anode technology," stated Maciej Jastrzebski, co-founder and CEO. "Ultimately, this grant will help our mission to secure a more sustainable battery materials supply chain for North American next-generation battery makers, significantly advancing Li-Metal's progress to automotive-grade commercial production."

Through its previously announced joint development and commercialization agreement, Li-Metal will work with Blue Solution to advance the development, and test the performance of, the Company's lithium metal anodes for the automotive market. The proceeds of the Grant will be used to support the commercialization of technologies for reprocessing of lithium metal and production of ultra-thin high-performance low-cost lithium metal anodes. This will enable Li-Metal to supply battery materials and components needed for product qualification - a key step before next-generation batteries can be used in electric vehicles.

Next Generation Manufacturing Canada (NGen)

NGen is the industry-led not-for-profit organization that leads Canada's Advanced Manufacturing Supercluster. Its mandate is to help build world-leading advanced manufacturing capabilities in Canada for the benefit of Canadians. NGen works to strengthen collaboration among its membership of more than 4,500 manufacturers, technology companies, innovation centres, and researchers, and provides funding and business support to industry-led initiatives that aim to develop, apply, or scale-up transformative manufacturing solutions in Canada for commercialization in global markets.

On behalf of the Board

"Maciej Jastrzebski"
Maciej Jastrzebski
CEO and Director

About Li-Metal Corp.

Li-Metal is a Canadian-based company developing lithium metal anodes and lithium metal production technologies for use in next generation batteries. Our production methods are significantly more sustainable than existing products and offer lighter, more energy dense and safer batteries that are critical to tomorrow's electric vehicles. For more information visit, www.li-metal.com.

Forward-Looking Information

This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company. Any such forward-looking statements may be identified by words such as "expects", "anticipates", "believes", "projects", "plans" and similar expressions. Readers are cautioned not to place undue reliance on forward-looking statements. Statements about, among other things, the Company's strategic plans are forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that the development of the business of the Company will be completed as described above. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.

Investor Contact

For more information on Li-Metal or to be added to the Company's email distribution list, please contact:
Salisha Ilyas
ir@li-metal.com
Tel: 647-795-1653

Media Contact

Harry Nicholas
Li-MetalPR@icrinc.com

SOURCE: Li-Metal Corp.



View source version on accesswire.com:
https://www.accesswire.com/699333/Li-Metal-Selected-for-5-Million-Industry-Consortium-to-Advance-Lithium-Metal-Solid-State-Batteries

© 2022 ACCESSWIRE
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.